Study of Autologous Peripheral Blood Lymphocytes in the Treatment of Patients With CLL or SLL
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1/2, study evaluating IOV-2001 (Adoptive Cell Therapy) composed of autologous
PBL (Peripheral Blood Lymphocytes) in patients with CLL/SLL, which has relapsed or is
relapsing during treatment with ibrutinib or acalabrutinib.